Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
about
Vaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalEffects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseasesRituximab for Rheumatoid Arthritis.Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveImpact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.The effect of rituximab on vaccine responses in patients with immune thrombocytopeniaShould my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapyRobust memory responses against influenza vaccination in pemphigus patients previously treated with rituximabVaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.Vaccinations in patients with immune-mediated inflammatory diseases2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Vaccinations for rheumatoid arthritis.Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study.Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?The observation of humoral responses after influenza vaccination in patients with rheumatoid arthritis treated with Japanese oriental (kampo) medicine: an observational study.An audit of influenza vaccination status in adults with inflammatory bowel diseaseTreatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis.Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.Rituximab-treated patients have a poor response to influenza vaccinationThe effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus.Rituximab for the treatment of rheumatoid arthritis: an update.Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy.Are anti-infectious vaccinations safe and effective in patients with autoimmunity?How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).Vaccination against infection in patients with multiple sclerosis.B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.Vaccines and biologics.Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.Vaccination of patients with autoimmune inflammatory rheumatic diseases.Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis.Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.Update on the use of rituximab for intractable rheumatoid arthritis.Factors affecting immune responses to the influenza vaccine.
P2860
Q26749096-FAE98390-AE70-49F6-9F16-BCEAC346C71DQ26825440-8998AE1B-4A12-4838-82E0-EDBBBF417712Q28080246-4579DDDC-6D2C-4B88-ACD7-205A026A0B3CQ28740919-90933DD9-AAB8-4564-A092-0D38BA7FE72CQ30400508-F5F6D9D0-A7C0-410E-83FA-D7F5E103663BQ30401020-213C5853-4F1E-4A32-8B63-AC8C74896100Q33409067-5705E9F8-1F98-452C-991E-7068CAAF566AQ33779792-5C3E63C3-0604-4F42-809A-6C3E73E7C188Q33785074-6E42DDD4-413A-4EC9-A393-101E102FA30EQ33798060-C2039FC5-BEDC-431E-89F7-5455095A2883Q34027585-4DB5B656-148E-4E26-968B-F411240A27BDQ34117134-F5E34E1C-73E8-4E35-974C-73AF7BE1EAF6Q34390072-CBD6F297-A6DD-4408-A3E5-524E9EA67721Q34424563-8E341DAB-111B-4C8B-A858-5491D9850206Q34431953-9A7B2041-92F6-4250-8AE2-AEBE6AE6FFF8Q35237511-04DD8E31-CD5A-4722-AB88-D8C8C0CBD3C4Q35942685-5DD43A33-B56C-4DA7-9332-FB037884B5D2Q36231818-65179B17-4B90-48CE-8AA9-F37F3770FF8AQ36362219-3A1C57E7-5121-43F1-9A2C-B6409F13CC25Q36367842-D5D8A4B7-4A64-4349-9BFD-20E1F9A052F8Q36488282-78FBF565-EA2F-4CE4-A8F4-42A142012749Q36589247-21141D62-EE1E-4CEB-ACCB-16A839AD8833Q36761926-DF008516-BE8F-41B0-B4A4-3DD55B3ED67AQ37342515-9B43A846-B312-44E7-A6EC-63EE8986DD63Q37444678-FD452A9B-6D6E-4FE3-BFCC-533CFE39407DQ37552019-441BC9DA-F7C4-4DFC-9A4A-ADBB2A15751FQ37762551-E731FE67-901A-425D-9DA9-54D56C8BC637Q37870212-D5DFE4EC-D0D5-4C7E-BF7C-2867645F5D5BQ37974891-CCB6ACAC-CD07-41D2-AA3C-3D529EEF9D07Q37978121-28DC091E-F10B-4CA1-9199-3A3B0A5DA887Q38097170-9E681784-1B99-4C8A-A08F-1C48848CC129Q38169909-03FF85A9-2A62-4061-B7FE-A5E340CF0840Q38171461-A47EEFE1-93F6-46A4-916C-208D52500CF3Q38213192-7FBE26A8-78F0-4D4A-BCC2-07DE212EA9E5Q38266287-C9DBD8CC-D1BD-4F22-BAA6-F2F5D46A2729Q38285275-5F75E248-BEBA-43BA-96E6-C6333D293FB1Q38316279-29597BDF-77E2-4FB2-ACDB-709F57869D48Q38842494-C2D0C213-9810-448C-AFEA-FAFDFA3ACC45Q38993240-B0846ED4-CB69-4EAB-B095-8F7AACAD853EQ39375320-75C9FB58-7D48-4EA8-9267-D369650C737A
P2860
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Vaccination against influenza ...... ximab on the humoral response.
@en
Vaccination against influenza ...... ximab on the humoral response.
@nl
type
label
Vaccination against influenza ...... ximab on the humoral response.
@en
Vaccination against influenza ...... ximab on the humoral response.
@nl
prefLabel
Vaccination against influenza ...... ximab on the humoral response.
@en
Vaccination against influenza ...... ximab on the humoral response.
@nl
P2093
P356
P1476
Vaccination against influenza ...... ximab on the humoral response.
@en
P2093
Balbir-Gurman A
Braun-Moscovici Y
Comaneshter D
Levartovsky D
Litinsky I
Mandelboim M
P304
P356
10.1136/ARD.2007.077461
P407
P577
2007-11-02T00:00:00Z